Fulcrum Capital’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.56M | Buy |
|
|||||
|
2025
Q1 | $4.2M | Buy |
|
|||||
|
2024
Q4 | $4.47M | Buy |
|
|||||
|
2024
Q3 | $4.76M | Buy |
|
|||||
|
2024
Q2 | $4.41M | Buy |
|
|||||
|
2024
Q1 | $4.34M | Sell |
|
|||||
|
2023
Q4 | $4.12M | Buy |
|
|||||
|
2023
Q3 | $3.34M | Buy |
|
|||||
|
2023
Q2 | $3.77M | Sell |
|
|||||
|
2023
Q1 | $3.61M | Sell |
|
|||||
|
2022
Q4 | $3.97M | Buy |
|
|||||
|
2022
Q3 | $3.64M | Sell |
|
|||||
|
2022
Q2 | $3.52M | Sell |
|
|||||
|
2022
Q1 | $6.59M | Buy |
|
|||||
|
2021
Q4 | $7.32M | Buy |
|
|||||
|
2021
Q3 | $7.49M | Buy |
|
|||||
|
2021
Q2 | $7.61M | Buy |
|
|||||
|
2021
Q1 | $7.24M | Sell |
|
|||||
|
2020
Q4 | $7.96M | Buy |
|
|||||
|
2020
Q3 | $6.23M | Sell |
|
|||||
|
2020
Q2 | $6.81M | Sell |
|
|||||
|
2020
Q1 | $5.13M | Sell |
|
|||||
|
2019
Q4 | $6.38M | Buy |
|
|||||
|
2019
Q3 | $5.02M | Buy |
|
|||||
|
2019
Q2 | $5.69M | Sell |
|
|||||
|
2019
Q1 | $6.55M | Buy |
|
|||||
|
2018
Q4 | $4.99M | Buy |
|
|||||
|
2018
Q3 | $6.39M | Sell |
|
|||||
|
2018
Q2 | $6.75M | Sell |
|
|||||
|
2018
Q1 | $6.55M | Buy |
|
|||||
|
2017
Q4 | $6.33M | Buy |
|